A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.

Goff LW, Cohen RB, Berlin JD, de Braud FG, Lyshchik A, Noberasco C, Bertolini F, Carpentieri M, Stampino CG, Abbattista A, Wang E, Borghaei H
Clin Cancer Res. 2016 22 (9): 2146-54

PMID: 26655846 · PMCID: PMC7328801 · DOI:10.1158/1078-0432.CCR-15-1622

MeSH Terms (14)

Activin Receptors, Type II Adult Aged Aged, 80 and over Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Agents Dose-Response Relationship, Drug Female Humans Male Middle Aged Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: